Literature DB >> 3126727

Binding of apolipoprotein A-I and apolipoprotein A-IV to cultured bovine aortic endothelial cells.

N Savion1, A Gamliel.   

Abstract

Adult bovine aortic endothelial (ABAE) cells specifically bound 125I-labelled high density lipoprotein3 (125I-HDL3), and saturation of the binding was observed at a concentration of about 50 to 100 micrograms protein/ml. The binding of purified apolipoproteins (apo) A-I and A-IV to cultured ABAE cells and the correlation of this binding with the binding of HDL to the cells was studied. ABAE cells bound 125I-labelled apo A-I (125I-apo A-I) and after a 3-hour exposure to the ligand, most of the radioactivity (82%) was associated with the cell surface and was accessible for trypsinization. Saturation of 125I-apo A-I binding was observed at a concentration of 3 micrograms/ml; each cell possessed 1.38 X 10(5) high affinity binding sites (Kd = 2.04 X 10(-8) M). The cultures also bound 125I-labelled apo A-IV (125I-apo A-IV), and saturation of the binding was observed at a concentration of 2 micrograms/ml. Each cell possessed 5.4 X 10(4) high affinity binding sites for apo A-IV (Kd = 1.45 X 10(-8) M). Addition of either excess unlabelled apo A-I or excess unlabelled apo A-IV competed with the binding of both iodinated apo A-I and apo A-IV. It suggests that apo A-I and A-IV share the same binding site on endothelial cells. HDL also successfully competed with the binding of apo A-I and A-IV to ABAE cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3126727     DOI: 10.1161/01.atv.8.2.178

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  5 in total

1.  The terminal complement proteins C5b-9 augment binding of high density lipoprotein and its apolipoproteins A-I and A-II to human endothelial cells.

Authors:  K K Hamilton; P J Sims
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

2.  Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein.

Authors:  D J Rader; J Schäfer; P Lohse; B Verges; M Kindt; L A Zech; A Steinmetz; H B Brewer
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

3.  Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population.

Authors:  A von Eckardstein; H Funke; M Schulte; M Erren; H Schulte; G Assmann
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

4.  Specific sequences in N termini of apolipoprotein A-IV modulate its anorectic effect.

Authors:  Fei Wang; Kevin J Pearson; W Sean Davidson; Patrick Tso
Journal:  Physiol Behav       Date:  2013-07-30

5.  ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT.

Authors:  Adelina Duka; Panagiotis Fotakis; Dimitra Georgiadou; Andreas Kateifides; Kalliopi Tzavlaki; Leonard von Eckardstein; Efstratios Stratikos; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2012-11-06       Impact factor: 5.922

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.